Search

everythinglearnresearchcommunity

for

Search:↓

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Key genes crucial for sheep hair follicle development were identified, aiding fine wool breeding and human hair loss research.

The gel with icariin speeds up wound healing, reduces scarring, and helps hair growth by controlling BMP4 signaling. It also reduces inflammation and improves wound quality in mice, adapts to different wound shapes, and gradually releases icariin to aid healing. It also prevents too much collagen and myofibroblast formation during skin healing.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Baricitinib is a promising treatment for alopecia areata.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Baricitinib may effectively treat oral lichen planus.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Ruxolitinib can cause a delayed skin reaction on the nose.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Type I interferons play a key role in the development of various skin diseases.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Using patients' own fat-derived cells to treat alopecia areata significantly improved hair growth and was safe.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.